Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese

Tumor Biology

Volumn 34, Issue 6, 2013, Pages 3681-3685

  Li, Yi ^a   Huang, Yi ^b   Cao, Yu Shu ^a   Zeng, Jia ^a   Tong, Wan Ning ^a   Xu, Shi Lin ^a   Zhuo, An Shan ^a  

^a No 411 Hospital of PLA   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Lung cancer; Polymorphism; XRCC1 Arg399Gln

Indexed keywords

XRCC1 PROTEIN;

ARTICLE; CANCER RISK; CHINESE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUNG CANCER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 84891485340     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0950-5     Document Type: Article

References (35)

1. Wen C, Dehnel T. China wrestles with lung cancer. Lancet Oncol. 2011;12:15.
2. She J, Yang P, Hong Q, Bai C. Lung cancer in China: challenges and interventions. Chest. 2013;143:1117-26.
3. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359:1367-80.
4. Brennan P, Hainaut P, Boffetta P. Genetics of lung-cancer susceptibility. Lancet Oncol. 2011;12:399-408.
5. Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou G, et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res. 2004;64:4378-84.
6. Ginsberg G, Angle K, Guyton K, Sonawane B. Polymorphism in the DNA repair enzyme xrcc1: utility of current database and implications for human health risk assessment. Mutat Res. 2011;727:1-15.
7. Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009;361:1475-85.
8. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability - an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11:220-8.
9. Bristow RG, Hill RP. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer. 2008;8:180-92.
10. Chen S, Tang D, Xue K, Xu L, Ma G, Hsu Y, et al. DNA repair gene xrcc1 and xpd polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis. 2002;23:1321-5.
11. Hu Z, Ma H, Lu D, Zhou J, Chen Y, Xu L, et al. A promoter polymorphism (-77t>c) of DNA repair gene xrcc1 is associated with risk of lung cancer in relation to tobacco smoking. Pharmacogenet Genomics. 2005;15:457-63.
12. Shen M, Berndt SI, Rothman N, Mumford JL, He X, Yeager M, et al. Polymorphisms in the DNA base excision repair genes apex1 and xrcc1 and lung cancer risk in Xuan Wei, China. Anticancer Res. 2005;25:537-42.
13. Zhang X, Miao X, Liang G, Hao B, Wang Y, Tan W, et al. Polymorphisms in DNA base excision repair genes adprt and xrcc1 and risk of lung cancer. Cancer Res. 2005;65:722-6.
14. Yin J, Vogel U, Ma Y, Qi R, Sun Z, Wang H. The DNA repair gene xrcc1 and genetic susceptibility of lung cancer in a northeastern Chinese population. Lung Cancer. 2007;56:153-60.
15. Li M, Yin Z, Guan P, Li X, Cui Z, Zhang J, et al. Xrcc1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers. Lung Cancer. 2008;62:145-51.
16. Yin J, Vogel U, Ma Y, Qi R, Wang H. Association of DNA repair gene xrcc1 and lung cancer susceptibility among nonsmoking Chinese women. Cancer Genet Cytogenet. 2009;188:26-31.
17. Li Z, Guan W, Li MX, Zhong ZY, Qian CY, Yang XQ, et al. Genetic polymorphism of DNA base-excision repair genes (ape1, ogg1 and xrcc1) and their correlation with risk of lung cancer in a Chinese population. Arch Med Res. 2011;42:226-34.
18. Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138-46.
19. Guo S, Li X, Gao M, Li Y, Song B, Niu W. The relationship between xrcc1 and xrcc3 gene polymorphisms and lung cancer risk in northeastern Chinese. PLoS One. 2013;8:e56213.
20. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
22. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
23. Song Y, Yi L, Pu Y, Liang G, Cui H. Relationship between polymorphisms of DNA repair gene xrcc1 and susceptibility to lung cancer in Nanjing population [article in Chinese]. J Environ Occup Med. 2004;21:18-21.
24. Li J, Mu L, Wei G, Chen C, Zhang Z, Yu S, et al. Relationship between polymorphisms of DNA repair gene xrcc1 and susceptibility to lung cancer [article in Chinese]. China Oncol. 2005;15:335-8.
25. Li M, Cui Z, He Q, Zhou B. Association of genetic polymorphism in the DNA repair gene xrcc1 with susceptibility to lung cancer in non-smoking women [article in Chinese]. Chin J Oncol. 2005;27:713-6.
26. Li MC, Cui ZS, He QC, Zhou BS. Association of genetic polymorphism in the DNA repair gene xrcc1 with susceptibility to lung cancer in non-smoking women. Zhonghua Zhong Liu Za Zhi. 2005;27:713-6.
27. Zhang W, Wu Y, Wu Y. Study on polymorphism of xrcc 1 and susceptibility to lung cancer [article in Chinese]. Chin J Publ Health. 2005;21:561-3.
28. Hao B, Miao X, Li Y, Zhang X, Sun T, Liang G, et al. A novel t-77c polymorphism in DNA repair gene xrcc1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene. 2006;25:3613-20.
29. Yu H, Zeng X, Qiu X, Xu S, Shi L, Zhang X, et al. Polymorphisms in the DNA repair gene xrcc1 and susceptibility to human lung cancer [article in Chinese]. J Guangxi Med Univ. 2006;23:355-8.
30. Su J, Niu R, Liu L, Han X, Shi J. Regression analysis between polymorphisms of DNA repair gene xrcc1 and susceptibility to lung cancer of nonsmoking women [article in Chinese]. J Zhengzhou Univ (Med Sci). 2008;43:234-8.
31. Wang N, Wu YJ, Zhou XL, Wu YM. The polymorphisms of xrcc1 gene and susceptibility to pulmonary cancer. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2012;30:41-4.
32. Liu C, Yin Q, Hu J, Li L, Zhang Y, Wang Y. A meta-analysis of evidences on xpc polymorphisms and lung cancer susceptibility. Tumour Biol. 2013;34:1205-13.
33. Wang S, Zhu J, Zhang R, Gu Z. Association between microsomal epoxide hydrolase 1 t113c polymorphism and susceptibility to lung cancer. Tumour Biol. 2013;34:1045-52.
34. Dai L, Duan F, Wang P, Song C, Wang K, Zhang J. Xrcc1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep. 2012;39:9535-47.
35. Wu J, Liu J, Zhou Y, Ying J, Zou H, Guo S, et al. Predictive value of xrcc1 gene polymorphisms on platinum-based chemotherapy in advanced non-small cell lung cancer patients: a systematic review and meta-analysis. Clin Cancer Res. 2012;18:3972-81.